David Kakiashvili

Papers

Total Citations

103

H-Index

About

David Kakiashvili is a prominent urological oncologist whose research focuses on improving the early detection and risk stratification of prostate cancer. His major contributions center on refining the use of prostate-specific antigen (PSA) to reduce unnecessary biopsies and overdiagnosis of clinically insignificant disease. His highly cited 2020 study on the association between PSA density and pathologically significant prostate cancer, which has garnered over 100 citations, demonstrated how accounting for prostate volume can dramatically enhance the predictive accuracy of PSA testing. This work has helped establish PSA density as a critical tool for identifying men who harbor aggressive tumors while sparing others from invasive procedures. Beyond this landmark paper, Kakiashvili has published extensively on novel biomarkers and imaging techniques for prostate cancer diagnosis. His research has been instrumental in shifting clinical practice toward more personalized, risk-adapted screening strategies. With a career dedicated to bridging the gap between diagnostic innovation and patient outcomes, Kakiashvili is recognized as a leading voice in the quest to make prostate cancer detection both more precise and less burdensome for patients.